Alnylam Pharmaceuticals Inc (ALNY)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$234.11

Buy

$248.00

arrow-up$0.64 (+0.26%)

Prices updated at 24 Apr 2025, 23:18 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
NASDAQ
arrow-up2.74%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$243.69 - $238.62
$304.39 - $141.98
-
31,317.34m
-
-
676,957
466.81
870,821.35
0.31
129.29m
US02043Q1076
-2.18
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.